Drug name - Treximet

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7332183 CURRAX Multilayer dosage forms containing NSAIDs and triptans
Oct, 2025

(2 years from now)

US7332183

(Pediatric)

CURRAX Multilayer dosage forms containing NSAIDs and triptans
Apr, 2026

(3 years from now)

Drugs and Companies using NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE ingredient

Market Authorisation Date: 15 April, 2008

Treatment: Treatment of migraine; Acute treatment of migraine

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
60MG;EQ 10MG BASE TABLET;ORAL Discontinued
500MG;EQ 85MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.